What we did
Capitalmind supported the CNIM Group throughout the entire sale process: preparation of marketing documentation, research and selection of strategic buyers and management of carve-out issues.
About the deal
Amatsi Group acquired the pharmaceutical development activities of Bertin Pharma.
Amatsi Group, a subsidiary of the Eurofins Group, is a pharmaceutical development company with a portfolio of 300+ international customers which includes players from both the pharmaceutical and biotechnology businesses. In 2016, the company generated revenues of 45 million euros and had more than 350 highly qualified employees in life sciences.